The CEOs of Merck and Johnson & Johnson have voluntarily agreed to testify at an upcoming Senate hearing on high drug prices in the U.S., Sen. Bernie …
Wealthy millennials are rejecting stocks for ‘alternative’ investments. What are they?
Older investors like stocks. Younger investors prefer "alternatives." That is the takeaway from a new Study of Wealthy Americans, published in June by Bank of America Private Bank. The bank surveyed 1,007 Americans with at least $3 million in investable assets. When...